MedPath
FDA Approval

Valganciclovir hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Ajanta Pharma USA Inc.
DUNS: 557554156
Effective Date
January 7, 2022
Labeling Type
Human Prescription Drug Label
Valganciclovir(50 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Ajanta Pharma Limited

918594859

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Ajanta Pharma Ltd., Dahej

Ajanta Pharma USA Inc.

Ajanta Pharma Limited

862199968

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Valganciclovir hydrochloride

Product Details

NDC Product Code
27241-159
Application Number
ANDA212890
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 10, 2022
Code: 4P3T9QF9NZClass: ACTIRQuantity: 50 mg in 1 mL
TARTARIC ACIDInactive
Code: W4888I119HClass: IACT
POVIDONE K30Inactive
Code: U725QWY32XClass: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EUClass: IACT
SACCHARIN SODIUMInactive
Code: SB8ZUX40TYClass: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
MALTODEXTRINInactive
Code: 7CVR7L4A2DClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
ACACIAInactive
Code: 5C5403N26OClass: IACT
TRIACETINInactive
Code: XHX3C3X673Class: IACT
.ALPHA.-TOCOPHEROLInactive
Code: H4N855PNZ1Class: IACT
OCTENYLSUCCINIC ACIDInactive
Code: 12UZE4X73LClass: IACT
© Copyright 2025. All Rights Reserved by MedPath